These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35219300)
1. Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis. Li N; Xiang X; Zhao D; Wang X; Tang Y; Chi Y; Yang L; Jiang L; Jiang J; Shi J; Liu W; Fang H; Tang Y; Chen B; Lu N; Jing H; Qi S; Wang S; Liu Y; Song Y; Li Y; Zhang L; Jin J BMC Cancer; 2022 Feb; 22(1):212. PubMed ID: 35219300 [TBL] [Abstract][Full Text] [Related]
2. Preoperative Chemoradiotherapy Yang W; Zhou M; Li G; Shen L; Wang Y; Zhang H; Wang Y; Zhang J; Sun X; Zhang Z; Zou W; Zhang Z Front Oncol; 2020; 10():560115. PubMed ID: 33178589 [TBL] [Abstract][Full Text] [Related]
3. Down-staging depth score to predict outcomes in locally advanced rectal cancer achieving ypI stage after neoadjuvant chemo-radiotherapy versus Li N; Jin J; Yu J; Li S; Tang Y; Ren H; Liu W; Wang S; Liu Y; Song Y; Fang H; Yu Z; Li Y Chin J Cancer Res; 2018 Jun; 30(3):373-381. PubMed ID: 30046231 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis. Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823 [TBL] [Abstract][Full Text] [Related]
5. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer. Lin Y; Lin H; Xu Z; Zhou S; Chi P J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538 [No Abstract] [Full Text] [Related]
6. Effect of adjuvant chemoradiotherapy on overall survival of gastric cancer patients submitted to D2 lymphadenectomy. Jácome AA; Wohnrath DR; Scapulatempo Neto C; Fregnani JH; Quinto AL; Oliveira AT; Vazquez VL; Fava G; Martinez EZ; Santos JS Gastric Cancer; 2013 Apr; 16(2):233-8. PubMed ID: 22740060 [TBL] [Abstract][Full Text] [Related]
7. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer. Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482 [TBL] [Abstract][Full Text] [Related]
8. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants. Ozden S; Ozgen Z; Ozyurt H; Gemici C; Yaprak G; Tepetam H; Mayadagli A World J Gastroenterol; 2015 Jan; 21(4):1222-33. PubMed ID: 25632196 [TBL] [Abstract][Full Text] [Related]
9. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis. Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study. Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026 [TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis. Girardi DM; de Lima MA; Pereira GCB; Negrão MV; López RVM; Capareli FC; Sabbaga J; Hoff PMG BMC Cancer; 2018 Apr; 18(1):378. PubMed ID: 29614980 [TBL] [Abstract][Full Text] [Related]
13. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis. Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895 [TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario. Kapoor R; Dracham CB; G Y S; Khosla D; Dey T; Elangovan A; Madan R; Yadav BS; Kumar N J Gastrointest Cancer; 2021 Jun; 52(2):616-624. PubMed ID: 32535755 [TBL] [Abstract][Full Text] [Related]
15. Ratio of metastatic to examined lymph nodes is a predictor of mortality in locally advanced gastric cancer treated chemo-radiotherapy. Unal D; Oguz A; Turak EE; Tasdemir A; Ozturk F; Kurtul N; Eroglu C Hepatogastroenterology; 2014 Oct; 61(135):2141-8. PubMed ID: 25713921 [TBL] [Abstract][Full Text] [Related]
16. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Park SE; Hwang IG; Choi CH; Kang H; Kim BG; Park BK; Cha SJ; Jang JS; Choi JH Medicine (Baltimore); 2018 Nov; 97(48):e13363. PubMed ID: 30508928 [TBL] [Abstract][Full Text] [Related]
18. Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis. Spiotto MT; Jefferson G; Wenig B; Markiewicz M; Weichselbaum RR; Koshy M JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):691-699. PubMed ID: 28426848 [TBL] [Abstract][Full Text] [Related]
19. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy. Sung S; Son SH; Park EY; Kay CS PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841 [TBL] [Abstract][Full Text] [Related]
20. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre. Tan E; Lam S; Han SP; Storey D; Sandroussi C Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]